For over 12 years, emotive has been creating behaviour-changing, connected experiences using digital and integrated communication channels. Dedicated solely to healthcare and serving leading clients around the globe, emotive’s mission is to combine strategic insight, technology, amazing client service and excellent execution to deliver creative, emotionally engaging experiences with a clear sense of purpose.
There was previously no infrastructure in the UK where comparisons could be made to judge the efficiency of different routes when looking at treatment and testing pathways in Non-Small Cell Lung Cancer. A patient pathway tool was developed in order to enable test centres to gauge their performance; build up an EGFR Patient Pathway network encompassing all test centres and ensure each EGFR M+ patient had the best chance possible of having optimised treatment. The tool was supported by EGFR eLearning and apps and a case study sharing website to share knowledge through peer-to-peer communication. The results surpassed all expectations with a 100% increase in oncologists considering EGFR testing to be very or extremely important. NICE recommend a 'test-all' approach so all eligible patients should now receive EGFR testing.
The treatment of heart failure (HF) is a key NHS priority. HF affects 900,000 people in the UK and costs the NHS over £2bn per annum. The current use of evidence-based medicine in patients with HF falls short of NICE recommendations.
The model was designed to enable Key Account Managers to engage with Commissioners and present bespoke financial benefits of improving the treatment of HF in their CCG.
Launched in March 2013, results within the first two months have been impressive. 96% of CCGs responded positively to the model and engagement has resulted in 7 new HF projects, with a further 14 in discussion. Projects include the setting up of specific HF clinics and the employment of HF specialist nurses.
The model was built in-house in two weeks using existing Apps and saved £50k+ in development costs. The project has already delivered a ROI for Servier, the NHS and patients.
With the launch of the Turbuhaler, a memorable educational experience was needed to help reps introduce the new device and demonstrate the benefits and ease of use to HCPs for all their patients. Augmented reality on an iPad was selected, allowing an immersive environment to be created that allowed for an exploratory, delightful experience and resulted in high recall and retention of key educational messages.
A tool that demonstrated how optimised medication usage can reduce wastage and increase productivity, while maintaining best care for patients was required. The vial sharing medicine optimisation app translates Excel formulae into HTML and JavaScipt code to calculate the most efficient combination of patients to treat, in order to maximise productivity through vial sharing, based on either the clinician's own patient data or default data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Now adopted by hospitals in the South East and South Yorkshire, the app has resulted in greater numbers of patents being treated within the limits of their existing budget.